To verify that these pathways affect cancer cell migration and invasion, we treated the cells with MAPK and IKK2 inhibitors (Figs. 3B and 3C); treatment with ERK, p38, and IKK2 inhibitors significantly reduced cell migration. The gene discussed is MAPK1; the disease is cancer.